BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31385177)

  • 1. Diagnostic role of kidney injury molecule-1 in renal cell carcinoma.
    Zhang KJ; Wilson GD; Kara S; Majeske A; Zhang PL; Hafron JM
    Int Urol Nephrol; 2019 Nov; 51(11):1893-1902. PubMed ID: 31385177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma.
    Zhang PL; Mashni JW; Sabbisetti VS; Schworer CM; Wilson GD; Wolforth SC; Kernen KM; Seifman BD; Amin MB; Geddes TJ; Lin F; Bonventre JV; Hafron JM
    Int Urol Nephrol; 2014 Feb; 46(2):379-88. PubMed ID: 23979814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue and urinary KIM-1 relate to tumor characteristics in patients with clear renal cell carcinoma.
    Mijuskovic M; Stanojevic I; Milovic N; Cerovic S; Petrovic D; Maksic D; Kovacevic B; Andjelic T; Aleksic P; Terzic B; Djukic M; Vojvodic D
    Int Urol Nephrol; 2018 Jan; 50(1):63-70. PubMed ID: 29052086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma: Potential noninvasive biomarkers.
    Mijugković M; Stanojević I; Milović N; Cerović S; Petrović D; Jovanović D; Aleksić P; Kovacević B; Andjelić T; Terzic B; Djukić M; Vojvodić D
    Vojnosanit Pregl; 2016 Mar; 73(3):266-72. PubMed ID: 27295912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
    Scelo G; Muller DC; Riboli E; Johansson M; Cross AJ; Vineis P; Tsilidis KK; Brennan P; Boeing H; Peeters PHM; Vermeulen RCH; Overvad K; Bueno-de-Mesquita HB; Severi G; Perduca V; Kvaskoff M; Trichopoulou A; La Vecchia C; Karakatsani A; Palli D; Sieri S; Panico S; Weiderpass E; Sandanger TM; Nøst TH; Agudo A; Quirós JR; Rodríguez-Barranco M; Chirlaque MD; Key TJ; Khanna P; Bonventre JV; Sabbisetti VS; Bhatt RS
    Clin Cancer Res; 2018 Nov; 24(22):5594-5601. PubMed ID: 30037816
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
    Morrissey JJ; London AN; Lambert MC; Kharasch ED
    Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
    Han WK; Alinani A; Wu CL; Michaelson D; Loda M; McGovern FJ; Thadhani R; Bonventre JV
    J Am Soc Nephrol; 2005 Apr; 16(4):1126-34. PubMed ID: 15744000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma.
    Shalabi A; Abassi Z; Awad H; Halachmi S; Moskovitz B; Kluger Y; Nativ O
    World J Urol; 2013 Dec; 31(6):1541-5. PubMed ID: 23430218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On normalizing of urinary KIM-1 level to urine creatinine in patients with renal cell cancer.
    Sergeeva NS; Kanukoev KY; Karmakova TA; Alentov II; Marshutina NV; Kaprin AD
    Klin Lab Diagn; 2021 Sep; 66(9):517-524. PubMed ID: 34543529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma.
    Kushlinskii NE; Gershtein ES; Naberezhnov DS; Taipov MA; Bezhanova SD; Pushkar' DY; Matveev VB; Stilidi IS
    Bull Exp Biol Med; 2019 Jul; 167(3):388-392. PubMed ID: 31346876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Human Kidney Injury Molecule1- (hKIM1-) is not Increased in Patients with Renal Cell Carcinoma.
    Bialek L; Poletajew S; Niemczyk M; Czerwinska K; Nowak M; Sadowska A; Borkowski T; Radziszewski P; Dobruch J; Kryst P
    Urol J; 2020 Oct; 17(6):664-666. PubMed ID: 33000456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
    Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
    Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
    Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney injury molecule-1 expression predicts structural damage and outcome in histological acute tubular injury.
    Cai J; Jiao X; Luo W; Chen J; Xu X; Fang Y; Ding X; Yu X
    Ren Fail; 2019 Nov; 41(1):80-87. PubMed ID: 30909833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic urinary miRNAs for the assessment of small renal masses.
    Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
    Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urine biomarkers for human renal cell carcinoma.
    Pastore AL; Palleschi G; Silvestri L; Moschese D; Ricci S; Petrozza V; Carbone A; Di Carlo A
    Dis Markers; 2015; 2015():251403. PubMed ID: 25922552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney injury molecule-1, a sensitive and specific marker for identifying acute proximal tubular injury, can be used to predict renal functional recovery in native renal biopsies.
    Yin W; Kumar T; Lai Z; Zeng X; Kanaan HD; Li W; Zhang PL
    Int Urol Nephrol; 2019 Dec; 51(12):2255-2265. PubMed ID: 31646460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
    Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
    Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
    Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
    Dis Markers; 2014; 2014():135649. PubMed ID: 24803718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma.
    Raina P; Singh SK; Goswami AK; Kashyap MK; Khullar M; Sharma SK; Barwal KC
    Mol Cell Biochem; 2022 Feb; 477(2):333-343. PubMed ID: 34716861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.